June 8, 2022 PRO Consortium Announces Publication of Open Access Article C-Path’s PRO Consortium is pleased to announce that “Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)
March 21, 2022 Recommendations to Optimize the Use of Volumetric MRI in Huntington’s Disease in Clinical Trials C-Path’s Huntington’s Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based biomark
September 29, 2021 Volumetric MRI-Based Biomarkers in Huntington’s Disease: An Evidentiary Review C-Path's Huntington's Disease Regulatory Science Consortium (HD-RSC) has published a new paper on volumetric MRI-based...
August 25, 2020 Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions C-Path’s Crohn's Disease Biomarkers Pre-Consortium funded by The Helmsley Charitable Trust is proud to announce its...
January 6, 2015 Critical Path Institute Secures Regulatory Support For Autosomal Dominant Polycystic Kidney Disease (ADPKD) Biomarker June 1, 2015 Critical Path Institute Secures Regulatory Support For Autosomal Dominant Polycystic Kidney Disease (ADPKD) Biomarke
Collaboration is Making LIFE Better: Critical Path Institute Celebrates Key Milestones AZ Bionindustry Association
C-Path Cosponsors Workshop on Combination Drug Development for Alzheimer’s Disease Combination therapy development has been successful in other life-threatening diseases in part because collaborative approaches we
